PLLA vs. HA Fillers: Key Differences in Long-Term Volume Restoration via Collagen Regeneration

PLLA vs. HA Fillers: Key Differences in Long-Term Volume Restoration via Collagen Regeneration

Table of Content [Hide]

    PLLA vs. HA Fillers: Key Differences in Long-Term Volume Restoration via Collagen Regeneration

    For years, hyaluronic acid (HA) fillers have dominated the facial rejuvenation market. However, a fundamental shift is underway — moving from physical occupancy to biological regeneration. For clinic owners and distributors targeting the 30+ demographic, understanding the clinical and economic differences between HA and poly-L-lactic acid (PLLA) is no longer optional.

    This article provides a data-driven comparison to help you position Collagen Stimulating Filler such as Singderm® PLLA within your portfolio.

    1. Mechanism of Action: Filling vs. Regenerating

    Hyaluronic Acid Fillers

    HA fillers work through physical occupation. They absorb water to create volume, but do not stimulate new collagen. The body degrades HA via hyaluronidase, typically within 6–12 months, requiring repeat touch-ups.

    PLLA (Poly-L-lactic acid) Fillers

    PLLA is a biodegradable synthetic polymer derived from natural sources (corn, cassava). As noted in Singderm’s clinical data, it acts as a Collagen Stimulating Filler:

    ·         Step 1 (Day 1): The PLLA suspension provides an immediate filling effect.

    ·         Step 2 (Days 3–14): Water is absorbed, and initial volume subsides. Simultaneously, PLLA activates fibroblasts.

    ·         Step 3 (Day 28 onwards): Fibroblasts produce Type III collagen (tissue repair) followed by Type I collagen (structural network rebuilding).

    ·         Result: A gradual, natural correction of depressions, lifting, and firming.


    2. Clinical Timeline & Collagen Regeneration Data

    Time Point

    HA Filler

    Singderm® PLLA Filler

    Immediate

    Full volume

    Temporary (carrier fluid)

    2 weeks

    Peak effect

    Initial volume subsides

    1–3 months

    Gradual degradation

    Collagen begins deposition

    6 months

    50-70% remaining

    93.6% wrinkle improvement (nasolabial)

    12–24 months

    Mostly gone

    18–24 months duration with active collagen

    Key clinical proof (Singderm multi-center, randomized, double-blind trial, n=275):
    At 6 months post-last injection, the improvement rate for nasolabial fold wrinkle score was 93.60% in the test group (Singderm PLLA), compared to 90.15% in the control group (domestic similar PLLA product).

    Additionally, over 24 months:

    ·         Type I collagen regeneration rate: up to 110.41%

    ·         Type III collagen regeneration rate: up to 20.89%

    No HA filler can produce such biological remodeling.

    3. Indications: Not Competitors, But Allies

    Best for HA Fillers

    ·         Dynamic wrinkles (crow’s feet, glabellar lines)

    ·         Lip augmentation

    ·         Tear troughs

    ·         Areas requiring reversibility

    Best for PLLA Fillers (Singderm®)

    ·         Deep volume loss: temples, cheeks, submalar regions

    ·         Sagging contours: jawline definition, nasolabial folds (fat pad descent type)

    ·         Large-area biostimulation: patients wanting gradual, natural lifting over 2 years

    Suggested Combination Protocol for Clinics

    ·         Deep layer: Singderm PLLA to rebuild collagen scaffold

    ·         Superficial layer: HA for fine detailing
    → Reduces total HA volume per patient → increases profit per session.

    4. Singderm® PLLA: Technical Advantages Over Other PLLA Products

    Based on Singderm’s internal comparison data (vs. European/American Brand S, Korean Brands, and Chinese Brands):

    Parameter

    Typical PLLA (Brand S/L)

    Singderm® PLLA

    Particle shape

    Irregular/flake-like

    Smooth microspheres

    Particle size (D50)

    40–63 μm

    20–50 μm (optimal   range)

    Reconstitution time

    2 hours – 24 hours

    1 minute

    Suspension stability

    Sedimentation within 60 min

    No obvious sedimentation within 60 min

    Raw material source

    Not specified

    German import, purity 99.9%

    Specifications

    Single (150mg PLLA)

    4 options (60/90/120/150mg   PLLA)

    Why smooth microspheres of 20–50 μm matter:

    ·         <20 μm → may be phagocytosed or pass through capillary walls

    ·         >50 μm → may cause inflammatory reactions/nodules

    ·         Smooth spheres induce lower immune response than irregular particles

    This makes Singderm a Collagen Stimulating Filler with both efficacy and safety.

    5. Economic Value for Clinics & Distributors

    For Clinics (per patient, 18-month horizon)

    Item

    HA-only protocol

    PLLA (Singderm) protocol

    Initial sessions

    1 session, repeat every 6–9 months

    3 sessions (1 month apart)

    Patient visits

    2–3 times per cycle

    2-3 visits per 18–24 months

    For Distributors

    ·         Differentiation: PLLA is a premium regenerative category, not commoditized like HA.

    ·         Cross-selling: Offer Singderm’s 4 specifications (60–150mg) for precise dosing – from preventive anti-aging (ages 25–30) to deep correction (ages 30–50+).

    ·         Support: Backed by granted patents in China and Germany, with US/UK applications pending.

    6. Practical Considerations: Reconstitution & Injection

    Singderm PLLA is a lyophilized powder requiring reconstitution:

    1.      Add 5mL sterile water for injection to 405mg vial (adjust for other specs).

    2.      Shake well, let stand 30 minutes to remove bubbles.

    3.      Use 22G needle to draw suspension, then switch to 26G needle for injection.

    4.      Inject into deep dermis at 30–40° angle, then advance at 10–20°.

    5.      Massage every 3–4 injection points for uniform distribution.

    Critical for clinics:
    Unlike product S which requires regular post-injection massage (due to flake-like particles), Singderm’s smooth microspheres allow better absorption with lower risk of nodules.

    7. Target Patient Profiles (from Singderm positioning)

    Type

    Age

    Need

    PLLA fit

    Naturalist Seeker

    30–50

    Avoid “frozen face”

    Gradual collagen regeneration

    Aesthetic Repair

    Any

    Correct previous HA/thread lift

    Physiological volume increase

    Premium Anti-aging

    35–50

    High-net-worth, refuse frequent touch-ups

    18–24 months effect

    Young Prevention

    25–30

    Early intervention

    Lower dose (60–90mg)

    Conclusion: Why Your Clinic or Distribution Should Include Singderm® PLLA

    HA fillers remain excellent for superficial lines and reversible needs. But for long-term, physiological volume restoration that leverages the body’s own collagen, poly-L-lactic acid filler is the future.

    Singderm® PLLA offers:

    ·         Proven clinical efficacy (93.6% wrinkle improvement)

    ·         Superior safety (smooth microspheres, German 99.9% purity)

    ·         Operational convenience (1-minute reconstitution, 60-minute stability)

    ·         Economic logic (higher patient LTV for clinics, differentiated SKUs for distributors)

    Learn more about Singderm Injectable PLLA Filler specifications & clinical data 



    References